Fennec Pharmaceuticals Statistics

Total Valuation

FENC has a market cap or net worth of $229.37 million. The enterprise value is $242.05 million.

Market Cap	229.37M
Enterprise Value	242.05M

Important Dates

The next confirmed earnings date is Thursday, August 14, 2025, before market open.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

FENC has 27.62 million shares outstanding. The number of shares has decreased by -3.63% in one year.

Current Share Class	27.62M
Shares Outstanding	27.62M
Shares Change (YoY)	-3.63%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	1.82%
Owned by Institutions (%)	26.32%
Float	14.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	16.34
PS Ratio	8.08
Forward PS	4.42
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	7.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.85

Current Ratio	4.85
Quick Ratio	4.30
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.98

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-11.20%
Return on Invested Capital (ROIC)	-28.57%
Return on Capital Employed (ROCE)	-26.54%
Revenue Per Employee	$1.04M
Profits Per Employee	-$376,156
Employee Count	32
Asset Turnover	0.62
Inventory Turnover	1.55

Taxes

In the past 12 months, FENC has paid $365,000 in taxes.

Income Tax	365,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.76% in the last 52 weeks. The beta is 0.40, so FENC's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+45.76%
50-Day Moving Average	8.39
200-Day Moving Average	6.63
Relative Strength Index (RSI)	61.49
Average Volume (20 Days)	53,304

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FENC had revenue of $33.30 million and -$12.04 million in losses. Loss per share was -$0.45.

Revenue	33.30M
Gross Profit	29.94M
Operating Income	-9.68M
Pretax Income	3.75M
Net Income	-12.04M
EBITDA	-9.34M
EBIT	-9.68M
Loss Per Share	-$0.45

Full Income Statement

Balance Sheet

The company has $18.71 million in cash and $19.36 million in debt, giving a net cash position of -$659,000 or -$0.02 per share.

Cash & Cash Equivalents	18.71M
Total Debt	19.36M
Net Cash	-659,000
Net Cash Per Share	-$0.02
Equity (Book Value)	-7.46M
Book Value Per Share	-0.27
Working Capital	32.38M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 89.89%, with operating and profit margins of -29.06% and -36.14%.

Gross Margin	89.89%
Operating Margin	-29.06%
Pretax Margin	-35.05%
Profit Margin	-36.14%
EBITDA Margin	-28.05%
EBIT Margin	-29.06%
FCF Margin	n/a

Dividends & Yields

FENC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.63%
Shareholder Yield	3.63%
Earnings Yield	-4.99%
FCF Yield	n/a

Analyst Forecast

The average price target for FENC is $13.00, which is 56.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	56.53%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	29.44%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 5, 2014. It was a reverse split with a ratio of 1:3.

Last Split Date	Sep 5, 2014
Split Type	Reverse
Split Ratio	1:3

Scores

Altman Z-Score	n/a
Piotroski F-Score	1